Hepatitis C and carotid atherosclerosis: A retrospective analysis

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 340-343

  Aslam, Fawad ^a   Alam, Mahboob ^a   Lakkis, Nasser M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cardiovascular; Hepatitis C; Inflammation

Indexed keywords

ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ATHEROSCLEROTIC PLAQUE; BRAIN ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; HEPATITIS C; HIGH RISK PATIENT; HUMAN; LETTER; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW;

CAROTID ARTERY DISEASES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED;

EID: 77950023123     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.10.006     Document Type: Letter

References (19)

1. de Groot E., Hovingh G.K., Wiegman A., et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004, 109:III33-III38.
2. Wang C.C., Lin S.K., Tseng Y.F., et al. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2009, 24:1411-1416.
3. Alyan O., Kacmaz F., Ozdemir O., et al. Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon Severity Score system. Circ J 2008, 72:1960-1965.
4. Sartori M.T., Bilora F., Zanon E., et al. Endothelial dysfunction in haemophilia patients. Haemophilia 2008, 14:1055-1062.
5. Yang K.C., Chen M.F., Su T.C., et al. Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese. Atherosclerosis 2007, 195:392-397.
6. Arcari C.M., Nelson K.E., Netski D.M., Nieto F.J., Gaydos C.A. No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis 2006, 43:e53-e56.
7. Malatino L.S., Mallamaci F., Benedetto F.A., et al. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis 2000, 36:945-952.
8. Kato K., Matsuhisa M., Ichimaru N., et al. The impact of new-onset diabetes on arterial stiffness after renal transplantation. Endocr J 2008, 55:677-683.
9. Ishizaka N., Ishizaka Y., Takahashi E., et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 2002, 105:1028-1030.
10. Bilora F., Rinaldi R., Boccioletti V., Petrobelli F., Girolami A. Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. Gastroenterol Clin Biol 2002, 26:1001-1004.
11. Ishizaka Y., Ishizaka N., Takahashi E., et al. Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J 2003, 67:26-30.
12. Fukui M., Kitagawa Y., Nakamura N., Yoshikawa T. Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. J Am Med Assoc 2003, 289:1245-1246.
13. Völzke H., Schwahn C., Wolff B., et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 2004, 174:99-103.
14. Targher G., Bertolini L., Padovani R., et al. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol 2007, 46:1126-1132.
15. Boddi M., Abbate R., Chellini B., et al. HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques. Dig Liver Dis 2007, 39:S55-S60.
16. Bilora F., Campagnolo E., Rinaldi R., et al. Carotid and femoral atherosclerosis in chronic hepatitis C: a 5-year follow-up. Angiology 2008, 59:717-720.
17. Caliskan Y., Oflaz H., Pusuroglu H., et al. Hepatitis C virus infection in hemodialysis patients is not associated with insulin resistance, inflammation and atherosclerosis. Clin Nephrol 2009, 71:147-157.
18. Tien P.C., Schneider M.F., Cole S.R., et al. Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study. AIDS 2009, 23:1781-1784.
19. Sawayama Y., Okada K., Maeda S., et al. Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy. Fukuoka Igaku Zasshi 2006, 97:245-255.